86 related articles for article (PubMed ID: 35606887)
1. Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response.
Qin Q; Zhou Y; Guo J; Chen Q; Tang W; Li Y; You J; Li Q
Genome Med; 2024 Apr; 16(1):47. PubMed ID: 38566132
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia.
Triki H; Declerck K; Charfi S; Ben Kridis W; Chaabane K; Ben Halima S; Sellami T; Rebai A; Berghe WV; Cherif B
Cancer Immunol Immunother; 2022 May; 71(5):1139-1155. PubMed ID: 34608548
[TBL] [Abstract][Full Text] [Related]
3. Methylation of nonessential genes in cutaneous melanoma - Rule Out hypothesis.
Gorlov IP; Conway K; Edmiston SN; Parrish EA; Hao H; Amos CI; Tsavachidis S; Gorlova OY; Begg C; Hernando E; Cheng C; Shen R; Orlow I; Luo L; Ernstoff MS; Kuan PF; Ollila DW; Tsai YS; Berwick M; Thomas NE
Melanoma Res; 2023 Jun; 33(3):163-172. PubMed ID: 36805567
[TBL] [Abstract][Full Text] [Related]
4. Enhancer methylation dynamics contribute to cancer plasticity and patient mortality.
Bell RE; Golan T; Sheinboim D; Malcov H; Amar D; Salamon A; Liron T; Gelfman S; Gabet Y; Shamir R; Levy C
Genome Res; 2016 May; 26(5):601-11. PubMed ID: 26907635
[TBL] [Abstract][Full Text] [Related]
5. Targeted DNA Methylation Editing Using an All-in-One System Establishes Paradoxical Activation of
Banerjee R; Ajithkumar P; Keestra N; Smith J; Gimenez G; Rodger EJ; Eccles MR; Antony J; Weeks RJ; Chatterjee A
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473261
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of the transcriptional landscape of melanoma reveals drug-target expression plasticity.
Balderson B; Fane M; Harvey TJ; Piper M; Smith A; Bodén M
Brief Funct Genomics; 2024 Jan; ():. PubMed ID: 38183207
[TBL] [Abstract][Full Text] [Related]
7. Exploring combined effects of DNA methylation and copy number on gene expression with a two-stage approach.
Claussen H; Ghosh S; Chen J
IEEE/ACM Trans Comput Biol Bioinform; 2024 May; PP():. PubMed ID: 38809726
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of recurrent CDC20 promoter variants in human melanoma.
Godoy PM; Oyedeji A; Mudd JL; Morikis VA; Zarov AP; Longmore GD; Fields RC; Kaufman CK
Commun Biol; 2023 Nov; 6(1):1216. PubMed ID: 38030698
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.
Rius FE; Papaiz DD; Azevedo HFZ; Ayub ALP; Pessoa DO; Oliveira TF; Loureiro APM; Andrade F; Fujita A; Reis EM; Mason CE; Jasiulionis MG
Clin Epigenetics; 2022 May; 14(1):68. PubMed ID: 35606887
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
12. Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients.
Papaiz DD; Rius FE; Ayub ALP; Origassa CS; Gujar H; Pessoa DO; Reis EM; Nsengimana J; Newton-Bishop J; Mason CE; Weisenberger DJ; Liang G; Jasiulionis MG
Mol Oncol; 2022 May; 16(9):1913-1930. PubMed ID: 35075772
[TBL] [Abstract][Full Text] [Related]
13. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis.
Azevedo H; Pessoa GC; de Luna Vitorino FN; Nsengimana J; Newton-Bishop J; Reis EM; da Cunha JPC; Jasiulionis MG
Clin Epigenetics; 2020 Aug; 12(1):127. PubMed ID: 32831131
[TBL] [Abstract][Full Text] [Related]
14. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]